German med schools perfectly OK with pharma-rep visits and gifts

German med school deans aren't too concerned with pharma reps swaying their students' future prescription habits, according to a recent survey. The findings: Only two of 30 responding universities had created guidelines for staff and students on dealing with pharma companies, and only 6 said they desired those guidelines. "That's a remarkably low number," one study conductor said. "We're behind the U.S. on this by 10 to 15 years." More

Suggested Articles

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.

Keytruda's U.S. NSCLC sales might start to fall as soon as early 2020, one analyst says, as I-O rivals eat into its share based on recent successes.

A small group of physicians expressed little interest in new MS drugs from Novartis, Merck KGaA and Biogen but favored a repurposed therapy.